Free Trial

Palisade Bio (PALI) Earnings Date, Estimates & Call Transcripts

Palisade Bio logo
$1.75 -0.05 (-2.78%)
(As of 12/20/2024 05:31 PM ET)

Palisade Bio Latest Earnings Summary

Actual EPS
(Nov. 12)
-$2.32 Beat By $1.03
Consensus EPS
(Nov. 12)
-$3.35

Palisade Bio announced Q3 2024 earnings on November 12, 2024, reporting an EPS of -$2.32, which topped analysts' consensus estimates of -$3.35 by $1.03. With a trailing EPS of -$13.98, Palisade Bio's earnings are expected to grow next year, from ($12.43) to ($2.99) per share.

Get Palisade Bio Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Palisade Bio and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

PALI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PALI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Palisade Bio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20241-$2.39-$2.39-$2.39

Palisade Bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/12/2024--$3.35-$2.32+$1.03-$2.32--
8/12/2024Q2 2024--$3.32 -$3.32-$3.32--
5/13/2024Q1 2024--$4.59 -$4.59-$4.59--
3/26/2024Q4 2023--$3.75 -$3.75-$3.75--
11/9/2023Q3 2023-$6.00-$7.35 -$1.35-$0.49--
8/11/2023Q2 2023--$7.95 -$7.95-$0.53--
5/12/2023Q1 2023--$8.10 -$8.10-$0.54-$0.25M

Palisade Bio Earnings - Frequently Asked Questions

Palisade Bio (NASDAQ:PALI) last announced its quarterly earning data on Tuesday, November 12, 2024. Learn more on PALI's earnings history.

In the previous quarter, Palisade Bio (NASDAQ:PALI) reported ($2.32) earnings per share (EPS) to beat the analysts' consensus estimate of ($3.35) by $1.03. Learn more on analysts' earnings estimate vs. PALI's actual earnings.

Palisade Bio (NASDAQ:PALI) has a recorded annual revenue of $250,000.00.

Palisade Bio (NASDAQ:PALI) has a recorded net income of -$12.30 million. PALI has generated -$13.98 earnings per share over the last four quarters.

Palisade Bio's earnings are expected to grow from ($12.43) per share to ($2.99) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:PALI) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners